Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC)
Status:
Terminated
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety in patients with non-muscle
invasive bladder cancer histologically diagnosed to be stage Ta and G1 or G2 and who were
randomized into either an EO9 or placebo group after TURBT.